报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 23.95% | 99.42% | 59.45% | 3/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | 15.02% | 170.14% | 103.8% | 3/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 7.37% | 595.28% | -56.42% | 2/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 16.91% | 555.43% | 40.8% | 6/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 12.01% | 574.72% | 116.01% | 12/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 5.56% | 3606.67% | 424.53% | 32/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 1.06% | 239.47% | -58.91% | 88/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | 2.58% | 221.7% | 44.94% | 94/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 1.78% | -61.72% | 1086.67% | 97/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 0.15% | 103.68% | 119.74% | 116/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | -0.76% | 50.97% | 64.15% | 120/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | -2.12% | 92.73% | -145.59% | 119/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | 4.65% | 2% | 213.97% | 82/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | -4.08% | 69.69% | -163.23% | 130/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2021-03-31 | -1.55% | 2% | 94.68% | 118/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
2020-12-31 | -29.15% | -0.14% | -116.57% | 136/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
2020-06-30 | -13.46% | 2% | 53.76% | 127/160 | 4.24% | 汇宇制药 | 55.94% | 行业排名> |
2019-12-31 | -29.11% | 2% | 2% | 128/160 | 2.78% | 河化股份 | 45.32% | 行业排名> |